Eradat, Herbert <br/><br/>
Venetoclax for the Treatment of Chronic Lymphocytic Leukemia.  [electronic resource] 

 -  Current hematologic malignancy reports  10 2019 
 - 469-476 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1558-822X 
<br/><br/><label>Standard No.: </label>10.1007/s11899-019-00539-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Biomarkers, Tumor<br/>Bridged Bicyclo Compounds, Heterocyclic--administration & dosage<br/>Chromosome Aberrations<br/>Disease Progression<br/>Drug Resistance, Neoplasm<br/>Gene Expression Regulation, Leukemic<br/>Genetic Predisposition to Disease<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis<br/>Molecular Targeted Therapy<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Recurrence<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome